{
    "Trade/Device Name(s)": [
        "Elecsys BRAHMS PCT"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K173927",
    "Predicate Device Reference 510(k) Number(s)": [
        "K171338"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PMT",
        "PRI",
        "NTM"
    ],
    "Summary Letter Date": "December 22, 2017",
    "Summary Letter Received Date": "December 26, 2017",
    "Submission Date": "December 22, 2017",
    "Regulation Number(s)": [
        "21 CFR 866.3215"
    ],
    "Regulation Name(s)": [
        "Device to detect and measure non-microbial analyte(s) in human clinical specimens to aid in assessment of patients with suspected sepsis"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Procalcitonin (PCT)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma (K2-EDTA, K3-EDTA, Li-Heparin)"
    ],
    "Specimen Container(s)": [
        "K2-EDTA tube",
        "K3-EDTA tube",
        "Li-Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Elecsys immunoassay analyzer",
        "cobas e immunoassay analyzers",
        "cobas e 411 analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemiluminescence immunoassay (ECLIA)",
        "Sandwich immunoassay"
    ],
    "Methodologies": [
        "Quantitative immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Kit",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for Elecsys BRAHMS PCT immunoassay to quantitatively measure procalcitonin in serum and plasma using electrochemiluminescence technology on Elecsys and cobas e analyzers",
    "Indications for Use Summary": "Immunoassay for the quantitative determination of procalcitonin in human serum and plasma to aid in risk assessment of progression to severe sepsis or septic shock, assess 28-day mortality risk in diagnosed patients, and support antibiotic therapy decisions for lower respiratory tract infections and sepsis, used with other laboratory and clinical findings",
    "fda_folder": "Microbiology"
}